South Asian Low-sodium Trial
NCT05136911 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2021-11-30
Summary
The overall goal of this pilot study is to examine the feasibility and acceptability of a culturally-tailored low-sodium dietary intervention is South Asian Canadians with stage one HTN. Specific objectives are to determine the feasibility (recruitment, retention, engagement and acceptability) of this intervention. Secondary outcomes include the effect of low-sodium dietary intervention on knowledge, attitude and self-regulation behaviours. Exploratory outcomes include its effect of systolic, diastolic blood pressure and sodium intake. Information obtained from this pilot trial will inform design of a larger randomized controlled trial in reducing BP in South Asian Canadians.
Conditions
Interventions
- BEHAVIORAL
-
SALT-Intervention
Participants in the intervention group will have access to all standard care as provided to the usual care group participants. In addition, participants in the intervention group will receive the SALT-intervention developed by the principal investigator in the form of a SALT-intervention consist of the Salt Intervention manual, five online modules which include a virtual cooking demonstration and five ten-minute weekly telephone calls delivered by the principal investigator.These strategies aim to increase knowledge, enhance self-management abilities and provide social support.
Sponsors & Collaborators
-
University of Toronto
lead OTHER
Principal Investigators
-
Salima Hemani, RN, PhD C. · University of Toronto, Lawrence S. Bloomberg Faculty of Nursing
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-27
- Primary Completion
- 2020-04-29
- Completion
- 2020-04-29
Countries
- Canada
Study Locations
More Related Trials
-
A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone
NCT01456169 ·Status: COMPLETED ·Phase: PHASE3
-
Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet
NCT00518765 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension
NCT00591773 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy Adults
NCT01078376 ·Status: TERMINATED ·Phase: PHASE1
-
COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus
NCT00526279 ·Status: COMPLETED
-
Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension
NCT00847626 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of High and Low Sodium Diets on Blood Pressure in Hypertensive Patients Treated With Aliskiren
NCT00441064 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study of ALT-BB4 to Determine Tolerance, Safety and Pharmacokinetics in Healthy Volunteer
NCT05232175 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension
NCT00591266 ·Status: COMPLETED ·Phase: PHASE3
-
Azilsartan Circadian and Sleep Pressure
NCT01762501 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension
NCT05359068 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult Volunteers
NCT02916901 ·Status: COMPLETED ·Phase: PHASE1
-
Salt Loading and Thiazide Intervention Study
NCT00896389 ·Status: COMPLETED ·Phase: PHASE4
-
ACE Inhibition and Novel Cardiovascular Risk Factors
NCT00051389 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of LCZ696A in Patients With Essential Hypertension
NCT00549770 ·Status: COMPLETED ·Phase: PHASE2
-
Valsartan Intensified Primary Care Reduction of Blood Pressure Study
NCT00902304 ·Status: COMPLETED ·Phase: PHASE4
-
New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering
NCT01609959 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension
NCT00591578 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Atacand® (Candesartan) in Daily Medical Practice
NCT00837720 ·Status: COMPLETED
-
Comparison of Two Treatment Strategies in Hypertensive Patients
NCT00171444 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.
NCT01033071 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension
NCT01615198 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension
NCT00696384 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension
NCT07191899 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
NCT00698646 ·Status: COMPLETED ·Phase: PHASE4